Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia.
Marshall HS, McMillan M, Koehler AP, Lawrence A, Sullivan TR, MacLennan JM, Maiden MCJ, Ladhani SN, Ramsay ME, Trotter C, Borrow R, Finn A, Kahler CM, Whelan J, Vadivelu K, Richmond P. Marshall HS, et al. Among authors: koehler ap. N Engl J Med. 2020 Jan 23;382(4):318-327. doi: 10.1056/NEJMoa1900236. N Engl J Med. 2020. PMID: 31971677 Clinical Trial.
Evaluating the effectiveness of the 4CMenB vaccine against invasive meningococcal disease and gonorrhoea in an infant, child and adolescent program: protocol.
Marshall HS, Andraweera PH, Wang B, McMillan M, Koehler AP, Lally N, Almond S, Denehy E, A'Houre M, Giles LC, Flood L. Marshall HS, et al. Among authors: koehler ap. Hum Vaccin Immunother. 2021 May 4;17(5):1450-1454. doi: 10.1080/21645515.2020.1827614. Epub 2021 Jan 11. Hum Vaccin Immunother. 2021. PMID: 33428528 Free PMC article.
B Part of It School Leaver Study: A Repeat Cross-Sectional Study to Assess the Impact of Increasing Coverage With Meningococcal B (4CMenB) Vaccine on Carriage of Neisseria meningitidis.
McMillan M, Koehler AP, Lawrence A, Sullivan TR, Bednarz J, MacLennan JM, Maiden MCJ, Ladhani SN, Ramsay ME, Trotter C, Borrow R, Finn A, Kahler CM, Whelan J, Vadivelu K, Richmond PC, Marshall HS. McMillan M, et al. Among authors: koehler ap. J Infect Dis. 2022 Feb 15;225(4):637-649. doi: 10.1093/infdis/jiab444. J Infect Dis. 2022. PMID: 34487174
B Part of It protocol: a cluster randomised controlled trial to assess the impact of 4CMenB vaccine on pharyngeal carriage of Neisseria meningitidis in adolescents.
Marshall HS, McMillan M, Koehler A, Lawrence A, MacLennan JM, Maiden MCJ, Ramsay M, Ladhani SN, Trotter C, Borrow R, Finn A, Sullivan T, Richmond P, Kahler CM, Whelan J, Vadivelu K. Marshall HS, et al. BMJ Open. 2018 Jul 10;8(7):e020988. doi: 10.1136/bmjopen-2017-020988. BMJ Open. 2018. PMID: 29991629 Free PMC article.
B Part of It School Leaver protocol: an observational repeat cross-sectional study to assess the impact of a meningococcal serogroup B (4CMenB) vaccine programme on carriage of Neisseria meningitidis.
Marshall HS, McMillan M, Koehler A, Lawrence A, MacLennan J, Maiden M, Ramsay M, Ladhani SN, Trotter C, Borrow R, Finn A, Sullivan T, Richmond P, Kahler C, Whelan J, Vadivelu K. Marshall HS, et al. BMJ Open. 2019 May 6;9(5):e027233. doi: 10.1136/bmjopen-2018-027233. BMJ Open. 2019. PMID: 31064808 Free PMC article. Clinical Trial.
Safety of meningococcal B vaccine (4CMenB) in adolescents in Australia.
Marshall HS, Koehler AP, Wang B, A'Houre M, Gold M, Quinn H, Crawford N, Pratt N, Sullivan TR, Macartney K. Marshall HS, et al. Among authors: koehler ap. Vaccine. 2020 Aug 18;38(37):5914-5922. doi: 10.1016/j.vaccine.2020.07.009. Epub 2020 Jul 22. Vaccine. 2020. PMID: 32712083
An Observational Study to Assess the Effectiveness of 4CMenB against Meningococcal Disease and Carriage and Gonorrhea in Adolescents in the Northern Territory, Australia-Study Protocol.
Marshall HS, Andraweera PH, Ward J, Kaldor J, Andrews R, Macartney K, Richmond P, Krause V, Koehler A, Whiley D, Giles L, Webby R, D'Antoine H, Karnon J, Baird R, Lawrence A, Petousis-Harris H, De Wals P, Greenwood-Smith B, Binks M, Whop L. Marshall HS, et al. Vaccines (Basel). 2022 Feb 16;10(2):309. doi: 10.3390/vaccines10020309. Vaccines (Basel). 2022. PMID: 35214767 Free PMC article.
Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhoea in an infant, child, and adolescent programme: an observational cohort and case-control study.
Wang B, Giles L, Andraweera P, McMillan M, Almond S, Beazley R, Mitchell J, Lally N, Ahoure M, Denehy E, Koehler A, Flood L, Marshall H. Wang B, et al. Lancet Infect Dis. 2022 Jul;22(7):1011-1020. doi: 10.1016/S1473-3099(21)00754-4. Epub 2022 Apr 12. Lancet Infect Dis. 2022. PMID: 35427492
37 results